Micro-Albumin: Definition and Detection

Definition of Micro-Albumin

Microalbuminuria is a medical term used to describe the presence of a specific range of abnormal albumin levels in the urine. It is characterized by a slight increase in the excretion of albumin, a protein, in the urine. The term "microalbuminuria" was coined to highlight the detection of small yet abnormal amounts of albumin in the urine, which can be indicative of underlying health issues.

Microalbuminuria is defined as the excretion of 30-300 mg of albumin per 24 hours, or 20-200 mcg/min, or 30-300 mcg/mg creatinine, based on 2 out of 3 urine collections. Detecting microalbuminuria is crucial as it can indicate the early stages of diabetic kidney disease.

Spot Collection	Timed Collection	24 hour Collection	Category
Less than 30 mcg/mg creatinine	Less than 20 mcg/min	Less than 30 mg	Normal
30-300 mcg/mg creatinine	20-200 mcg/min	30-300 mg	Microalbuminuria
More than 300 mcg/mg creatinine	More than 200 mcg/min	More than 300 mg	Clinical albuminuria

Mechanisms of Micro-Albumin

Under normal circumstances, the kidneys filter waste products from the blood, including albumin, and prevent their excretion in the urine. However, when there is damage or dysfunction in the kidneys or the renal system, small amounts of albumin may leak into the urine.

Proteinuria can occur due to three primary mechanisms. The first mechanism involves glomerular injury, which leads to increased filtration of proteins. The second mechanism is tubular injury, causing excessive production and excretion of tubular proteins, such as Tamm-Horsfall protein. The third mechanism involves the overfiltration of plasma proteins due to high plasma concentrations, as seen in multiple myeloma. Various diseases, including glomerular and tubular diseases, can contribute to the excessive excretion of proteins in the urine.

Clinical Significance of Micro-Albumin

Microalbuminuria serves as a vital clinical marker with significant implications for various medical conditions, particularly those affecting the kidneys and cardiovascular system. It plays a crucial role in the early detection, diagnosis, and monitoring of kidney diseases and cardiovascular complications. Some key points regarding the clinical significance of microalbuminuria include:

Early detection of kidney disease: Microalbuminuria is considered an early sign of kidney damage and can be an important indicator of renal dysfunction. It is particularly relevant in conditions such as diabetic nephropathy (kidney disease associated with diabetes) and hypertensive nephropathy (kidney disease caused by high blood pressure). Detecting microalbuminuria in its early stages allows timely interventions to slow down disease progression and preserve renal function.

Predicting cardiovascular risk: Microalbuminuria has been identified as an independent risk factor for cardiovascular disease (CVD). Studies have shown that individuals with microalbuminuria are at a higher risk of developing cardiovascular events, such as heart attacks and strokes. It is believed that the presence of microalbuminuria reflects increased vascular permeability and endothelial dysfunction, which are associated with atherosclerosis and other cardiovascular complications.

Monitoring treatment response: Microalbuminuria is used to monitor the response to therapies aimed at preserving kidney function and reducing cardiovascular risk. In patients with diabetes, effective management of blood glucose levels, blood pressure, and lipid profiles can help reduce microalbuminuria and slow the progression of kidney disease. Regular monitoring of microalbuminuria levels allows healthcare professionals to assess treatment efficacy and make necessary adjustments.

Prognostic value: Elevated levels of microalbuminuria have been associated with a higher risk of adverse outcomes in various patient populations. For example, individuals with chronic kidney disease (CKD) and microalbuminuria are at an increased risk of progressing to end-stage renal disease (ESRD) and experiencing cardiovascular events. Monitoring microalbuminuria provides valuable prognostic information, helping to identify high-risk patients who may require more intensive management and follow-up.

Screening tool: Microalbuminuria is used as a screening tool in specific populations, such as individuals with diabetes or hypertension, to detect early signs of kidney disease and cardiovascular risk. Routine screening with simple urine tests can identify patients who require further evaluation and intervention.

Detection Methods for Micro-Albumin

To detect and quantify albuminuria, there are two main methods available:

Dipstick Test Strips: These strips are designed to detect microalbuminuria and provide a semi-quantitative estimate of albumin levels. They offer high sensitivity and specificity, and they can be used in the office setting. However, they do not provide precise quantitative measurements and require confirmation with another test. Dipstick test strips are cost-effective but can give false positive or false negative results in diluted or concentrated urine samples.

Urine Albumin-to-Creatinine Ratio: This method is recommended as the preferred approach for quantifying albuminuria. It involves measuring the concentrations of albumin and creatinine in a random urine sample. The ratio is reported in milligrams of albumin per gram of creatinine (mg/g). The urine albumin-to-creatinine ratio improves sensitivity, and it is not affected by urine sample concentration. It is a direct and quantitative measurement and does not require 24-hour urine collection. This method is widely available in clinical laboratories.

Figure 1. Diagram of a test strip showing a top-view of its components and principle of a competitive strip test assay with microalbuminuria.
(Source: Vutthikraivit, N. et al., 2021)

Laboratory methods for albumin detection in urine include immunoturbidimetric, radioimmunoassay, and high-performance liquid chromatography. These methods can accurately measure albumin levels in urine, with high-performance liquid chromatography being particularly effective for detecting low levels of intact albumin molecules. It's worth noting that these methods may also detect albumin fragments, but the significance of detecting these fragments is not yet fully understood.

Microalbumin-Related ELISA Kits

Target	Cat. No.	Product Name	Size	Species Reactivity	Application	Detection Sample
Microalbumin	DEIA2299	Human Micro-Albumin ELISA Kit	96T	Human	Quantitative	Urine	Inquiry
Microalbumin	DEIA2299R	Human Micro-Albumin ELISA Kit	96T	Human	Quantitative	Urine	Inquiry
Creatinine	DEIABL-M4	Cr(Creatinine) Assay Kit(Colorimetric)	96T	Universal	Quantitative	serum, plasma, tissue homogenates and other biological fluids.	Inquiry
	DEIA-ZH073	Cr (Creatinine) Assay Kit (Colorimetric)	96T	Universal	Quantitative	Serum, Plasma and Urine	Inquiry
	DEIA-XYL4	Creatinine ELISA Kit	96T	Human, Research Animal	Quantitative	Urine, Forensic Matrices	Inquiry

Inquiry Basket

Loading ......

Inquiry

Target	Cat. No.	Product Name	Host	Isotype	Application
Creatinine	DPAB-DC4134	Anti-Creatinine polyclonal antibody	Sheep		EIA	Inquiry
Creatinine	DMAB27374	Anti-Creatinine Monoclonal antibody, clone NBC20353	Sheep		ELISA, WB, Dot, IHC, IA	Inquiry
Creatinine N	DPABY-827	Anti-Creatinine N polyclonal antibody	Sheep		ELISA, Pr*	Inquiry

Target	Cat. No.	Product Name	Expression System	Tag/Conjugate	Application
Creatinine	DAG-WT125	Recombinant Creatinase	E. coli	His	Immunoassay	Inquiry
	DAG-WT124	Recombinant Creatinine Amidohydrolase	E. coli	His	Immunoassay	Inquiry
	DAGA-369	Creatinine Standard (98%)	N/A	N/A	ELISA	Inquiry
	DAG-CL005	Creatinine-HRP		HRP	ELISA, Immunoassays	Inquiry
	DAGA-186G	Creatinine [BTG]	Synthetic	BTG	LFIA	Inquiry
	DAGA-186B	Creatinine Acid [BSA]	N/A	BSA	LFIA	Inquiry
	DAGA-186H	Creatinine Acid [HRP]	N/A	HRP	ELISA	Inquiry
	DAGA-186K	Creatinine Acid [KLH]	N/A	KLH	Immunogen	Inquiry
	DAG608S	Creatinine [BSA]	N/A	BSA	ELISA, LFIA	Inquiry
	DAG1075	Creatinine(N) [HRP]	N/A	HRP	N/A	Inquiry